Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lithium versus placebo for premenstrual dysphoric disorder
IRCT20251217068367N1Phase 3Recruiting
- Sponsor
- University of Social Welfare and Rehabilitation Sciences
- Start
- Apr 2026
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of lithium carbonate in Premenstrual Dysphoric Disorder (PMDD) (2 arms), sponsored by University of Social Welfare and Rehabilitation Sciences. Primary endpoint: Change in PMDD symptom severity. Started Apr 2026; status: recruiting.
02
Drugs
lithium carbonate
03
Conditions
Premenstrual Dysphoric Disorder (PMDD)
Beyond the preview
Go deeper on IRCT20251217068367N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251217068367N1.